References
- 1. Bamford J, at al.: Classif ication and natural history of clinically identifiable subtypes of cerebral infarction. Lancet, 337,1521-1526,1993.
- 2. Conolly SJ.: Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centres and countries as measured by time in therapeutic range. Circulation, 118, 2029-2037, 2008.
- 3. Crystal E, Connolly SJ: Role of oral anticoagulation in management of atrial fibrillation. Heart 20,813-817, 2004.
- 4. Garcia DA, Hylek EM.: Antithrombotic therapy in atrial fibrillation. Clin Geriatr Med, 22, 155-156, 2006.
- 5. Hart RG, at al.: Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies. Cedrebrovasc Dis, 10, 39-43, 2000.
- 6. Hart RG, Benavente O, McBride R, Pearce LA: Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a metaanalysis. Ann Intern Med, 131,492-501, 1999.
- 7. Hart RG, Halperin JL: Atrial fibrillation and stroke: concepts and controversies. Stroke 32, 803-808 , 2001.
- 8. Hayek E, Griffin B: Mitral valve prolapse: old beliefs yield to new knowledge. Cleve Clin J Med.69:889-896,2002.
- 9. Kernan WN, at al.: Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 45, 2160-2236, 2014.
- 10. Kim YD, at al.: Factors associated with ischemic stroke on therapeutic anticoagulation in patients with nonvalvular atrial fibrillation. Yonsei Med J, 56, 410-417, 2015.
- 11. Kohsaka S, at al.: Impact of mitral annular calcification on cardiovascular events in a multiethnic community: the Northern Manhattan Study. JACC Cardiovasc Imaging. 1, 617-623, 2008.
- 12. Lip GY, at al.: Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the EuroHeart Survey on Atrial Fibrillation. Chest, 137, 263-272, 2010.
- 13. Lip GY, at al.: ABC of atrial fibrillation. Aethiology, pathophysiology and clinical features. BMI 311,1425-1428,1995.
- 14. Pujol Leris W, at al.: Ischemic stroke in patients with atrial fibrillation receiving oral anticoagulation. J Neurol Sci, 334, 139-142, 2013.
- 15. Stramba-Badiale M.: Atriall fibrillation subtypes, risk of stroke, and antithrombotic therapy. Eur Heart J 29, 840-842, 2008.
- 16. Whitlock R, at al.: Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines. Chest, 141:576-600, 2012.